Skip to content

Clinical trials

Carcinoma, Hepatocellular trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Hepatocellular Country / region: United Kingdom Clear all

107 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20031
20041
20053
20071
20082
20094
20103
20112
20123
20136
20145
20157
20162
20179
20188
20198
20201
202110
20226
20236
20243
20259
20265

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed49
Recruiting22
Active, not recruiting13
Terminated13
Unknown status7
Not yet recruiting2
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bayer9
Imperial College London7
Hoffmann-La Roche6
University of Oxford6
Bristol-Myers Squibb5
Exelixis5
Eisai Inc.4
Merck Sharp & Dohme LLC3
Pfizer3
Polaris Group3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Hepatocellular107
Liver Neoplasms25
Neoplasms14
Carcinoma, Non-Small-Cell Lung13
Colorectal Neoplasms11
Cholangiocarcinoma9
Squamous Cell Carcinoma of Head and Neck8
Stomach Neoplasms8
Carcinoma, Renal Cell7
Fibrosis7

Trials

Showing 1 to 25 of 107. Each trial links to its page on Pharma Observatory.

7 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.